Search for Latest Active Tenders - Central

# keyword finds match in Tender Id,Tender Title,Tender Ref.No and Tender Description
Y72F8F
Enter the characters shown in the image.
Total Tenders : 29515
Sl.No e-Published Date Bid Submission Closing Date Tender Opening Date Title/Ref.No./Tender Id Organisation Name Corrigendum
27941. 21-Nov-2025 03:52 PM 29-Dec-2025 10:30 AM 29-Dec-2025 10:30 AM Trypan Blue 0.08 Percent , 0.1 Percent 2 ml vial like Visiblue DROP/72255473/106892963 Ministry of Railways --
27942. 21-Nov-2025 03:51 PM 29-Dec-2025 10:30 AM 29-Dec-2025 10:30 AM Timolol Maleate 0.5 Percent Eye Drops/72255472/106892961 Ministry of Railways --
27943. 21-Nov-2025 03:50 PM 29-Dec-2025 10:30 AM 29-Dec-2025 10:30 AM Beclamethasone Dipropionate IP 0.025 Percent w/w, Phenylephrine Hydrochloride IP 0.10 Percent w/w, Lignocaine Hydrochloride IP 2.5 Percent w/w in soft paraffin base like Anovate 20 gm Tube/72255471/106892958 Ministry of Railways --
27944. 21-Nov-2025 03:48 PM 29-Dec-2025 10:30 AM 29-Dec-2025 10:30 AM Oint. Clindamycin (1 Percent w/w) + Nicotinamide (4 Percent w/w) 10 gm Tube/72255470/106892956 Ministry of Railways --
27945. 21-Nov-2025 03:47 PM 29-Dec-2025 10:30 AM 29-Dec-2025 10:30 AM Fluticasone Nasal spray 50 mcg 120 MDI/72255469/106892951 Ministry of Railways --
27946. 21-Nov-2025 03:47 PM 29-Dec-2025 11:00 AM 29-Dec-2025 11:00 AM Galvanized Hook Bolts/81256328/106892968 Ministry of Railways --
27947. 21-Nov-2025 03:39 PM 29-Dec-2025 10:30 AM 29-Dec-2025 10:30 AM TAB. ROSUVASTATIN 20 MG/72255468/106892594 Ministry of Railways --
27948. 21-Nov-2025 03:38 PM 29-Dec-2025 10:30 AM 29-Dec-2025 10:30 AM TAB. ROSUVASTATIN 10 MG/72255467/106892583 Ministry of Railways --
27949. 21-Nov-2025 03:37 PM 29-Dec-2025 10:30 AM 29-Dec-2025 10:30 AM Tab. Cinnarizine 25mg/72255466/106892635 Ministry of Railways --
27950. 21-Nov-2025 03:36 PM 05-Jan-2026 01:30 PM 05-Jan-2026 01:30 PM Procurement of Paint Ready Mixed aluminium for general purposes etc./05251276/106892761 Ministry of Railways --

Note : For more details and clarifications, please refer to the respective Portal.